Biological and Clinical Aspects on the Treatment of Schizophrenia and Related Disorders: New Challenges

José Antonio Monreal; Alexandre González-Rodríguez

doi:10.3390/healthcare10091806

Biological and Clinical Aspects on the Treatment of Schizophrenia and Related Disorders: New Challenges

Healthcare (Basel). 2022 Sep 19;10(9):1806. doi: 10.3390/healthcare10091806.

Authors

José Antonio Monreal^{1

2}, Alexandre González-Rodríguez¹

Affiliations

¹ Department of Mental Health, Mutua Terrassa University Hospital, Fundació Docència I Recerca Mutua Terrassa, University of Barcelona (UB), CIBERSAM, 08221 Terrassa, Spain.
² Institut de Neurociències, Universitat Autònoma de Barcelona (UAB), 08221 Terrassa, Spain.

Abstract

For several decades, it has been postulated that dopaminergic pathways explain the neurobiology of schizophrenia, the biological underpinnings of treatment responses and the main mechanisms of action of antipsychotics [...].

Publication types

Editorial

Grants and funding

This research received no external funding.